Page last updated: 2024-11-07

prednisone and Dyslipidemia

prednisone has been researched along with Dyslipidemia in 6 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Research Excerpts

ExcerptRelevanceReference
" A logistic regression analysis showed age, gender, time on dialysis, diabetes, type of calcineurin inhibitor (CSA vs TAC), adjunctive therapy (SRL/EVR vs MMF) and prednisone dose to be associated with dyslipidemia."3.77Lipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimen. ( Felipe, CR; Mandia-Sampaio, EL; Medina-Pestana, JO; Park, SI; Spinelli, GA; Tedesco-Silva, H, 2011)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Benarous, X1
Brocheton, C1
Bonnay, C1
Boissel, L1
Crovetto, C1
Lahaye, H1
Guilé, JM1
Theret, P1
Gondry, J1
Foulon, A1
Kim, E1
Yoo, SH1
Chen, Z1
Sousa, JA1
Batista, E1
Demeyer, S1
Fischer, N1
Pellegrino, O1
Ribeiro, AS1
Martins, LL1
Worthy, FR1
Goldberg, SD1
Ranjitkar, S1
Xu, JC1
Asmara, AAGY1
Karna, MB1
Meregawa, PF1
Deslivia, MF1
Carula, BC1
Giostri, GS1
Bebber, F1
Batista, MFDS1
Silva, FBD1
Novak, EM1
Vilela, JCS1
Franco, N1
Campos, G1
Deligne, LM1
Machado, TLA1
Degasperi, FA1
Scatigna, BF1
Falótico, GG1
Romero, V1
Basile, R1
Takata, ET1
Kaleka, CC1
Debieux, P1
Antonioli, E1
Zucconi, E1
Cohen, M1
Ferretti, M1
Bampidis, V2
Azimonti, G2
Bastos, ML2
Christensen, H2
Fašmon Durjava, M2
Kouba, M2
López-Alonso, M2
López Puente, S2
Marcon, F2
Mayo, B2
Pechová, A2
Petkova, M2
Ramos, F2
Sanz, Y2
Villa, RE2
Woutersen, R2
Brantom, P2
Chesson, A2
Westendorf, J2
Manini, P2
Pizzo, F2
Dusemund, B2
Aron, J1
Albert, PS1
Gribble, MO1
Samankul, A1
Senawong, G1
Swatsitang, P1
Sripa, B1
Phaosiri, C1
Kanokmedhakul, S1
Senawong, T1
Sirajudeen, MS1
Alzhrani, M1
Alanazi, A1
Alqahtani, M1
Waly, M1
Unnikrishnan, R1
Muthusamy, H1
Alrubaia, W1
Alanazi, N1
Seyam, MK1
Kashoo, F1
Miraj, M1
Channmgere Govindappa, S1
Alghamdi, KA1
Al-Hussinan, NM1
Wang, Z2
Qu, T1
Qi, H1
Zhao, S1
Shi, H2
Bai, W1
Yu, Y1
Wu, X1
Zhao, P1
Yakubov, S1
Stockerl, WJ1
Tian, X1
Shahin, A1
Mandigma, MJP1
Gschwind, RM1
Barham, JP1
Li, R1
Jiang, D1
Du, P1
Yuan, C1
Cui, X1
Tang, Q1
Zheng, J1
Li, Y1
Lu, K1
Ren, X1
Gao, S1
Zhan, X1
Ramgoolam, KH1
Dolphin, AC1
Shi, Q1
Zhou, YJ1
Fang, JG1
Zhong, X1
Chen, LZ1
Hou, HZ1
Ma, L1
Feng, SZ1
He, JW1
Huang, R1
Wang, YF1
Yang, Y1
Guo, FL1
Li, LJ2
Ruan, XH2
Fu, GM1
Zhao, JZ2
Hou, XK1
Gao, M2
Zheng, XQ2
Zeng, Y1
Huang, DM1
Zhang, JM1
Zhang, H1
Kang, M1
Zhu, J1
Xu, YJ1
Li, SN1
Lai, JM1
Liu, JJ1
Wen, S1
Yan, HH1
Cheng, R1
Zhu, F1
Gao, PF1
Zou, HY1
Huang, CZ1
Wang, J1
AbdElgawad, H1
Zinta, G1
Hornbacher, J1
Papenbrock, J1
Markakis, MN1
Asard, H1
Beemster, GTS1
Fukushi, Y1
Akamine, Y1
Abumiya, M1
Tozawa, N1
Yamashita, T1
Nara, M1
Kameoka, Y1
Takahashi, N1
Miura, M1
Qi, G1
Yu, T1
Li, J1
Guo, Z1
Ma, K1
Jin, Y1
Lucon-Xiccato, T1
Montalbano, G1
Gatto, E1
Frigato, E1
D'Aniello, S1
Bertolucci, C1
Shi, W1
Ge, N1
Yu, S1
Wu, J1
Hu, T1
Wei, J1
Yan, X1
Wang, X1
Lin, K1
Deng, T1
Qu, H1
Ou, H1
Huang, Q1
Gao, B1
Li, X1
Wei, N1
von Haeften, K1
Laarmann, T1
Wabnitz, H1
Möller, T1
Gries, KJ1
Hart, CR1
Kunz, HE1
Ryan, Z1
Zhang, X1
Parvizi, M1
Liu, Y1
Dasari, S1
Lanza, IR1
Perez, HL1
Andonian, C1
Wan, KX1
Potts, D1
Gonzalez, P1
Smith, I1
Kavetska, O1
Monção, CSA1
Martins, LN1
Penteado, MPS1
Reis, RCP1
Santos, FMM1
Lanna, CCD1
Ribeiro, AL1
Telles, RW1
Taber, DJ1
Douglass, K1
Srinivas, T1
McGillicuddy, JW1
Bratton, CF1
Chavin, KD1
Baliga, PK1
Egede, LE1
Jumean, K1
Shaaban, H1
Raso, AA1
Sto Niño, OV1
Li-Yu, J1
Spinelli, GA1
Felipe, CR1
Park, SI1
Mandia-Sampaio, EL1
Tedesco-Silva, H1
Medina-Pestana, JO1

Reviews

1 review available for prednisone and Dyslipidemia

ArticleYear
    Neuropsychiatrie de l'enfance et de l'adolescence, 2023, Volume: 71, Issue:1

    Topics: Acceptance and Commitment Therapy; Adolescent; Adult; Aged; Aldehydes; Alpinia; Animals; Antibodies,

2023

Trials

1 trial available for prednisone and Dyslipidemia

ArticleYear
    Neuropsychiatrie de l'enfance et de l'adolescence, 2023, Volume: 71, Issue:1

    Topics: Acceptance and Commitment Therapy; Adolescent; Adult; Aged; Aldehydes; Alpinia; Animals; Antibodies,

2023

Other Studies

5 other studies available for prednisone and Dyslipidemia

ArticleYear
Incidence of cardiovascular risk factors in female patients with systemic lupus erythematosus: a 3-year follow-up cohort.
    Lupus, 2018, Volume: 27, Issue:11

    Topics: Adult; Age Factors; Brazil; Dyslipidemias; Female; Follow-Up Studies; Humans; Hypertension; Incidenc

2018
Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients.
    American journal of nephrology, 2014, Volume: 40, Issue:1

    Topics: Adult; Aged; BK Virus; Black or African American; Cardiovascular Diseases; Cohort Studies; Dyslipide

2014
Elderly Female With Perianal Rash.
    Annals of emergency medicine, 2016, Volume: 68, Issue:2

    Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Anus Diseases; Buttocks; Diabetes Mellitus, Ty

2016
Does prolonged systemic glucocorticoid use increase risk of tophus formation among gouty arthritis patients?
    International journal of rheumatic diseases, 2009, Volume: 12, Issue:3

    Topics: Adult; Aged; Amidohydrolases; Arthritis, Gouty; Comorbidity; Cross-Sectional Studies; Dyslipidemias;

2009
Lipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimen.
    Transplantation proceedings, 2011, Volume: 43, Issue:10

    Topics: Adult; Analysis of Variance; Biomarkers; Brazil; Chi-Square Distribution; Cyclosporine; Drug Therapy

2011